Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017)

Sintx Technologies (SINT) recorded quarterly Liabilities from Discontinued Operations of 2356000.0 in Q4 2017.

Sintx Technologies (SINT) Liabilities from Discontinued Operations (2017) Analysis & Trends

Sintx Technologies' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 2356000.0 for Q4 2017.

  • In Q4 2017, Liabilities from Discontinued Operations changed N/A year-over-year to 2356000.0; the TTM figure through Dec 2017 stood at 2356000.0 (changed N/A YoY), while the FY2017 annual figure was 2356000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 2356000.0 for Q4 2017 at Sintx Technologies.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 2356000.0 in Q4 2017 to a low of 2356000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Sintx Technologies 8.59 Mn 6.70 Mn 144,000.00

Historic Data

Download Data
DateValue
Dec 31, 2017 2.36 Mn
Dec 31, 2017 2.36 Mn